Works matching IS 00099236 AND DT 2017 AND VI 101 AND IP 5

Results: 30

Clinical Considerations for Oncolytic Viral Therapies: A Regulatory Perspective.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 580, doi. 10.1002/cpt.640
By:
- Liu, K
Publication type:
Article
Development and validation of algorithms for the detection of statin myopathy signals from electronic medical records.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 667, doi. 10.1002/cpt.526
By:
- Chan, SL;
- Tham, MY;
- Tan, SH;
- Loke, C;
- Foo, BPQ;
- Fan, Y;
- Ang, PS;
- Brunham, LR;
- Sung, C
Publication type:
Article
Issue Information.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 543, doi. 10.1002/cpt.477
Publication type:
Article
Data Sharing, Clinical Trials, and Biomarkers in Precision Oncology: Challenges, Opportunities, and Programs at the Department of Veterans Affairs.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 586, doi. 10.1002/cpt.660
By:
- Fiore, LD;
- Brophy, MT;
- Ferguson, RE;
- Shannon, C;
- Turek, SJ;
- Pierce‐Murray, K;
- Ajjarapu, S;
- Huang, GD;
- Lee, CSE;
- Lavori, PW
Publication type:
Article
Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 589, doi. 10.1002/cpt.666
By:
- Grossman, RL;
- Abel, B;
- Angiuoli, S;
- Barrett, JC;
- Bassett, D;
- Bramlett, K;
- Blumenthal, GM;
- Carlsson, A;
- Cortese, R;
- DiGiovanna, J;
- Davis‐Dusenbery, B;
- Dittamore, R;
- Eberhard, DA;
- Febbo, P;
- Fitzsimons, M;
- Flamig, Z;
- Godsey, J;
- Goswami, J;
- Gruen, A;
- Ortuño, F
Publication type:
Article
ASCPT NEWS.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 561, doi. 10.1002/cpt.669
Publication type:
Article
Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 684, doi. 10.1002/cpt.540
By:
- Tamm, R;
- Mägi, R;
- Tremmel, R;
- Winter, S;
- Mihailov, E;
- Smid, A;
- Möricke, A;
- Klein, K;
- Schrappe, M;
- Stanulla, M;
- Houlston, R;
- Weinshilboum, R;
- Mlinarič Raščan, Irena;
- Metspalu, A;
- Milani, L;
- Schwab, M;
- Schaeffeler, E
Publication type:
Article
Food Effect Studies for Oncology Drug Products.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 606, doi. 10.1002/cpt.610
By:
- Parsad, S;
- Ratain, MJ
Publication type:
Article
European Medicines Agency Perspective on Oncology Study Design for Marketing Authorization and Beyond.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 577, doi. 10.1002/cpt.612
By:
- Jonsson, B;
- Martinalbo, J;
- Pignatti, F
Publication type:
Article
Molecular 'Sameness' Is the Key Guiding Principle for Extrapolation to Multiple Indications.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 603, doi. 10.1002/cpt.616
By:
- McCamish, M;
- Woollett, GR
Publication type:
Article
Cancer prevention in the era of precision oncology.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 575, doi. 10.1002/cpt.566
By:
- Brahme, NN;
- Szabo, E
Publication type:
Article
Cancer Moonshot Data and Technology Team: Enabling a National Learning Healthcare System for Cancer to Unleash the Power of Data.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 613, doi. 10.1002/cpt.636
By:
- Hsu, ER;
- Klemm, JD;
- Kerlavage, AR;
- Kusnezov, D;
- Kibbe, WA
Publication type:
Article
Centers for Medicare & Medicaid Services' Oncology Care Model: Delivering Higher Value Cancer Care.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 569, doi. 10.1002/cpt.638
By:
- Mortimer, LK;
- Strawbridge, LM;
- Lukens, EW;
- Bassano, A;
- Conway, PH;
- Kline, RM
Publication type:
Article
National Cancer Institute Formulary: A Public-Private Partnership Providing Investigators Access to Investigational Anticancer Agents.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 616, doi. 10.1002/cpt.585
By:
- Cristofaro, JV;
- Ansher, SS;
- Zwiebel, JA;
- Ivy, P;
- Conley, B;
- Abrams, JS;
- Doroshow, JH
Publication type:
Article
Artificial intelligence (AI) systems for interpreting complex medical datasets.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 585, doi. 10.1002/cpt.650
By:
- Altman, RB
Publication type:
Article
Translation and Clinical Development of Bispecific T-cell Engaging Antibodies for Cancer Treatment.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 634, doi. 10.1002/cpt.651
By:
- Yuraszeck, T;
- Kasichayanula, S;
- Benjamin, JE
Publication type:
Article
Use of External Controls in Regulatory Decision-Making.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 595, doi. 10.1002/cpt.652
By:
- Jarow, JP
Publication type:
Article
Optimizing treatment for patients with anaplastic lymphoma kinase-positive lung cancer.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 625, doi. 10.1002/cpt.653
By:
- Dagogo‐Jack, I;
- Shaw, AT;
- Riely, GJ
Publication type:
Article
Charting a Course for Precision Oncology.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 593, doi. 10.1002/cpt.654
By:
- Kusnezov, D;
- Paragas, J
Publication type:
Article
Cancer Therapy: Shooting for the Moon.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 552, doi. 10.1002/cpt.655
By:
- Lee, JSH;
- Blumenthal, GM;
- Hohl, RJ;
- Huang, S‐M
Publication type:
Article
Association of time-varying clearance of nivolumab with disease dynamics and its implications on exposure response analysis.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 657, doi. 10.1002/cpt.656
By:
- Liu, C;
- Yu, J;
- Li, H;
- Liu, J;
- Xu, Y;
- Song, P;
- Liu, Q;
- Zhao, H;
- Xu, J;
- Maher, VE;
- Booth, BP;
- Kim, G;
- Rahman, A;
- Wang, Y
Publication type:
Article
Cancer Moonshot Connecting International Liquid Biopsy Efforts Through Academic Partnership.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 622, doi. 10.1002/cpt.657
By:
- Dive, C;
- Shishido, SN;
- Kuhn, P
Publication type:
Article
Collaboration to Accelerate Proteogenomics Cancer Care: The Department of Veterans Affairs, Department of Defense, and the National Cancer Institute's Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) Network.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 619, doi. 10.1002/cpt.658
By:
- Fiore, LD;
- Rodriguez, H;
- Shriver, CD
Publication type:
Article
Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 646, doi. 10.1002/cpt.659
By:
- Darwich, A S;
- Ogungbenro, K;
- Vinks, A A;
- Powell, J R;
- Reny, J‐L;
- Marsousi, N;
- Daali, Y;
- Fairman, D;
- Cook, J;
- Lesko, L J;
- McCune, J S;
- Knibbe, C A J;
- Wildt, S N;
- Leeder, J S;
- Neely, M;
- Zuppa, A F;
- Vicini, P;
- Aarons, L;
- Johnson, T N;
- Boiani, J
Publication type:
Article
In This Issue.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 551, doi. 10.1002/cpt.670
Publication type:
Article
Highlights.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 559, doi. 10.1002/cpt.671
Publication type:
Article
Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 675, doi. 10.1002/cpt.558
By:
- Arwood, MJ;
- Deng, J;
- Drozda, K;
- Pugach, O;
- Nutescu, EA;
- Schmidt, S;
- Duarte, JD;
- Cavallari, LH
Publication type:
Article
Impact of physiologically based pharmacokinetic models on regulatory reviews and product labels: Frequent utilization in the field of oncology.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 597, doi. 10.1002/cpt.622
By:
- Yoshida, K;
- Budha, N;
- Jin, JY
Publication type:
Article
Drug Development, Trial Design, and Endpoints in Oncology: Adapting to Rapidly Changing Science.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 572, doi. 10.1002/cpt.623
By:
- Blumenthal, GM;
- Goldberg, KB;
- Pazdur, R
Publication type:
Article
Toward greater insights on pharmacokinetics and exposure-response relationships for therapeutic biologics in oncology drug development.
Published in:
Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 5, p. 582, doi. 10.1002/cpt.628
By:
- Wang, Y;
- Booth, B;
- Rahman, A;
- Kim, G;
- Huang, SM;
- Zineh, I
Publication type:
Article